Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Post-transplant cyclophosphamide has become a promising medical option after allogeneic HSCT. In this study we aimed to evaluate the efficacy of cyclophosphamide and cyclosporine combination in acute and chronic graft-versus-host disease (GvHD) prophylaxis in acute myeloid leukemia (AML) cases sched...

Descripción completa

Detalles Bibliográficos
Autores principales: Namdaroglu, Sinem, Kaya, Ali Hakan, Batgi, Hikmettullah, Kayikci, Omur, Dal, Mehmet Sinan, Iskender, Dicle, Kizil Cakar, Merih, Tekgunduz, Emre, Altuntas, Fevzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376163/
https://www.ncbi.nlm.nih.gov/pubmed/30765830
http://dx.doi.org/10.1038/s41598-019-38644-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376163/
https://www.ncbi.nlm.nih.gov/pubmed/30765830
http://dx.doi.org/10.1038/s41598-019-38644-1

Ejemplares similares